SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Biomedical Advanced Research & Development Authority (BARDA) Accelerator Network Collaborative Virtual Series
Event | 07. 01. 2022
Art Pappas will be participating in BARDA's Accelerator Network Collaborative Virtual Series panel discussion titled "Scale your Company via Strategic Partnerships & Venture Financing" on July 1st from 12:00-1:30 PM EDT.
